Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Kaye

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
British Journal of Haematology|February 28, 2009
Epidemiology of immune thrombocytopenic purpura in the General Practice Research DatabaseW Marieke Schoonen, Gena Kucera, Jenna Coalson, et al.
Breast Cancer Research and Treatment|November 3, 2010
Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trialsJoanne L Blum, Joseph Kohles, Edward McKenna, et al.
British Journal of Haematology|April 10, 2010
Epidemiology of paediatric immune thrombocytopenia in the General Practice Research DatabaseMellissa Yong, Wilma Marieke Schoonen, Lin Li, et al.
Cancer Medicine|January 10, 2014
Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record reviewDebanjali Mitra, James A Kaye, Lance T Piecoro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 25, 2016
"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationaleSarah Marion, Spiros Tzivelekis, Christina Darden, et al.
Cancer Management and Research|November 4, 2014
A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancerGebra Cuyún Carter, Amy M Barrett, James A Kaye, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 15, 2018
Treatment Patterns and Health Outcomes in Platinum-Refractory or Platinum-Resistant Ovarian Cancer: A Retrospective Medical Record ReviewRohan Parikh, Samantha K Kurosky, Margarita Udall, et al.
Journal of Skin Cancer|June 14, 2017
A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell CarcinomaDawn Odom, Deirdre Mladsi, Molly Purser, et al.
Personalized Medicine|February 7, 2023
Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the USANaleen Raj Bhandari, Lisa M Hess, Rohan C Parikh, et al.
Pharmacoepidemiology and Drug Safety|February 28, 2022
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare databaseCatherine B Johannes, Catherine W Saltus, James A Kaye, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|February 28, 2009
Epidemiology of immune thrombocytopenic purpura in the General Practice Research DatabaseW Marieke Schoonen, Gena Kucera, Jenna Coalson, et al.
Breast Cancer Research and Treatment|November 3, 2010
Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trialsJoanne L Blum, Joseph Kohles, Edward McKenna, et al.
British Journal of Haematology|April 10, 2010
Epidemiology of paediatric immune thrombocytopenia in the General Practice Research DatabaseMellissa Yong, Wilma Marieke Schoonen, Lin Li, et al.
Cancer Medicine|January 10, 2014
Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record reviewDebanjali Mitra, James A Kaye, Lance T Piecoro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 25, 2016
"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationaleSarah Marion, Spiros Tzivelekis, Christina Darden, et al.
Cancer Management and Research|November 4, 2014
A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancerGebra Cuyún Carter, Amy M Barrett, James A Kaye, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 15, 2018
Treatment Patterns and Health Outcomes in Platinum-Refractory or Platinum-Resistant Ovarian Cancer: A Retrospective Medical Record ReviewRohan Parikh, Samantha K Kurosky, Margarita Udall, et al.
Journal of Skin Cancer|June 14, 2017
A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell CarcinomaDawn Odom, Deirdre Mladsi, Molly Purser, et al.
Personalized Medicine|February 7, 2023
Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the USANaleen Raj Bhandari, Lisa M Hess, Rohan C Parikh, et al.
Pharmacoepidemiology and Drug Safety|February 28, 2022
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare databaseCatherine B Johannes, Catherine W Saltus, James A Kaye, et al.
Pageof 11